Business Context and Reporting Period
Company: Phibro Animal Health Corporation (PAHC)
Filing Type: Form 8-K (Current Report)
Date of Report: August 28, 2024
Reporting Period: Fourth quarter and fiscal year ended June 30, 2024. The filing also includes financial guidance for the fiscal year ending June 30, 2025.
Key Financial Metrics
This Form 8-K serves as a notification of the issuance of a press release (Exhibit 99.1) containing the detailed operating results. The text of this specific filing does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes
The filing does not detail specific material changes or comparative financial data within the body of the report. It references the announcement of results for the period ended June 30, 2024, but does not quantify variances versus prior periods in this document.
Guidance, Outlook, and Risks
- Guidance: The company issued financial guidance for the fiscal year ending June 30, 2025, as detailed in the attached press release.
- Management Commentary: Specific commentary is contained within Exhibit 99.1 and is not summarized in the main text of this 8-K.
- Risks and Contingencies: No specific risks or contingencies are described in the body of this filing.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated August 28, 2024) for actual revenue, net income, and cash flow figures.
- Verify the specific numerical targets provided in the guidance for fiscal year 2025.
- Confirm the details of any unusual items or one-time charges mentioned in the full press release.